The muscle spasticity market is estimated to be valued at US$ 4,167.6 million in 2023 and is expected to exhibit a CAGR of 8.9% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.

 

Market Overview:

Muscle spasticity refers to a medical condition characterized by involuntary tightening or contracting of muscles. It is commonly seen in ... Read more

Muscle spasticity refers to tight or stiff muscles and increased reflexes occurring due to upper motor neuron disorders like multiple sclerosis, cerebral palsy, spinal cord injuries and stroke. The condition results in constant contractions of muscles which restrict normal movements. Treatment solutions for muscle spasticity include medication, therapies, injections and surgeries. Oral medications like baclofen and tizanidine help in reducing muscle tone while physical and occupational ... Read more

Muscle spasticity refers to involuntary muscle contractions that occur as a result of damage to the central nervous system caused due to conditions like multiple sclerosis, spinal cord injury, cerebral palsy, brain injury and stroke. If left untreated, spasticity can cause pain, discomfort and reduce mobility. Currently available treatment options include medications to reduce spasms, physical and occupational therapy, orthotic devices, surgeries and other invasive procedures. However, there ... Read more